D
SELLAS Life Sciences Group, Inc. SLS
$1.92 $0.0955.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 23.75% 24.24% 17.30% 15.77% 4.55%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1.47% -15.97% -17.79% -5.63% 1.28%
Change in Net Operating Assets -7,571.13% -374.08% -298.68% -171.53% -103.09%
Cash from Operations 2.49% -12.21% -12.71% -4.21% -5.13%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 100.00% -20.00%
Cash from Investing -- -- -- 100.00% -20.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 55.82% 45.29% 109.26% 152.26% 53.11%
Repurchase of Common Stock -106.45% -6.67% -6.67% -6.90% -6.90%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 55.77% 45.37% 109.54% 152.47% 53.18%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 446.57% 281.92% 177.81% 198.18% 64.64%